I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Dokoupilová, Eva
41
results:
Search for persons
X
Format
Online (41)
Mediatypes
Articles (Online) (24)
OpenAccess-fulltext (17)
Sorted by: Relevance
Sorted by: Year
?
1
Effect of treatment with original or biosimilar adalimumab ..:
Dokoupilová, Eva
;
Vetchý, David
;
Pavloková, Sylvie
.
International Journal of Pharmaceutics: X. 7 (2024) - p. 100229 , 2024
Link:
https://doi.org/10.1016/..
?
2
Equivalence trial of proposed denosumab biosimilar GP2411 a..:
Jeka, Sławomir
;
Dokoupilová, Eva
;
Kivitz, Alan
...
Journal of Bone and Mineral Research. 39 (2024) 3 - p. 202-210 , 2024
Link:
https://doi.org/10.1093/..
?
3
Usability Study of PF-06410293, an Adalimumab Biosimilar, b..:
Fleischmann, Roy M.
;
Bock, Amy E.
;
Zhang, Wuyan
...
Rheumatology and Therapy. 9 (2022) 3 - p. 839-850 , 2022
Link:
https://doi.org/10.1007/..
?
4
P171 Efficacy and safety of upadacitinib in patients with a..:
Genovese, Mark C
;
Lertratanakul, Apinya
;
Anderson, Jaclyn
...
Rheumatology. 60 (2021) Supplement_1 - p. , 2021
Link:
https://doi.org/10.1093/..
?
5
Clinical effectiveness and safety of intra-articular inject..:
Pavelka, Karel
;
Horváth, Rudolf
;
Hurnáková, Jana
...
Journal of Clinical Orthopaedics and Trauma. 19 (2021) - p. 75-80 , 2021
Link:
https://doi.org/10.1016/..
?
6
Upadacitinib in Patients with Psoriatic Arthritis and Inade..:
Mease, Philip J.
;
Lertratanakul, Apinya
;
Papp, Kim A.
...
Rheumatology and Therapy. 8 (2021) 2 - p. 903-919 , 2021
Link:
https://doi.org/10.1007/..
?
7
Efficacy and safety of secukinumab in patients with spondyl..:
Behrens, Frank
;
Sewerin, Philipp
;
de Miguel, Eugenio
...
Rheumatology. 61 (2021) 7 - p. 2856-2866 , 2021
Link:
https://doi.org/10.1093/..
?
8
Efficacy and Safety of Ixekizumab in Patients with Psoriati..:
Orbai, Ana-Maria
;
Gratacós, Jordi
;
Turkiewicz, Anthony
...
Rheumatology and Therapy. 8 (2020) 1 - p. 199-217 , 2020
Link:
https://doi.org/10.1007/..
?
9
Secukinumab 150/300 mg Provides Sustained Improvements in t..:
Pavelka, Karel
;
Kivitz, Alan J.
;
Dokoupilova, Eva
...
ACR Open Rheumatology. 2 (2020) 2 - p. 119-127 , 2020
Link:
https://doi.org/10.1002/..
?
10
Improvement of Signs and Symptoms of Nonradiographic Axial ..:
Deodhar, Atul
;
Blanco, Ricardo
;
Dokoupilová, Eva
...
Arthritis & Rheumatology. 73 (2020) 1 - p. 110-120 , 2020
Link:
https://doi.org/10.1002/..
?
11
An international, multicentre, double-blind, randomized stu..:
Pelletier, Jean-Pierre
;
Raynauld, Jean-Pierre
;
Dorais, Marc
...
Rheumatology. 59 (2020) 12 - p. 3858-3868 , 2020
Link:
https://doi.org/10.1093/..
?
12
Switching to Biosimilar SDZ-ADL in Patients with Moderate-t..:
Wiland, Piotr
;
Jeka, Sławomir
;
Dokoupilová, Eva
...
BioDrugs. 34 (2020) 6 - p. 809-823 , 2020
Link:
https://doi.org/10.1007/..
?
13
Upadacitinib for psoriatic arthritis refractory to biologic..:
Mease, Philip J
;
Lertratanakul, Apinya
;
Anderson, Jaclyn K
...
Annals of the Rheumatic Diseases. 80 (2020) 3 - p. 312-320 , 2020
Link:
https://doi.org/10.1136/..
?
14
FKB327, an adalimumab biosimilar, versus the reference prod..:
Genovese, Mark C.
;
Glover, Josephine
;
Greenwald, Maria
...
Arthritis Research & Therapy. 21 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
15
Switching From Reference Adalimumab to SB5 (Adalimumab Bios..:
Weinblatt, Michael E.
;
Baranauskaite, Asta
;
Dokoupilova, Eva
...
Arthritis & Rheumatology. 70 (2018) 6 - p. 832-840 , 2018
Link:
https://doi.org/10.1002/..
1-15